Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Feb;18(2):168-75.
doi: 10.2165/00003088-199018020-00006.

Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis

Affiliations

Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis

A Hedman et al. Clin Pharmacokinet. 1990 Feb.

Abstract

The steady-state renal clearance of cefsulodin was studied in 6 patients with cystic fibrosis and 8 healthy controls. The drug was administered by constant rate infusion to obtain 2 values of plasma concentration, 2 and 30 mg/L. As an estimate of the glomerular filtration rate, the renal clearance of inulin was measured simultaneously. The results showed the figures for inulin clearance to be approximately 30% higher in cystic fibrosis patients than in healthy controls at both concentrations, and a corresponding increase in the renal clearance of cefsulodin was seen in patients over controls. The ratio between the renal clearances of the 2 substances was on average 0.9 in both groups. The correlation found between the 2 renal clearances (r = 0.75; p less than 0.001) indicates that glomerular filtration rate has considerable influence on the renal elimination of cefsulodin. This finding emphasises the importance of glomerular filtration rate for the renal clearance of drugs in cystic fibrosis.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1984 Sep;36(3):355-62 - PubMed
    1. J Pediatr. 1979 Jan;94(1):163-4 - PubMed
    1. Antimicrob Agents Chemother. 1983 Mar;23(3):369-73 - PubMed
    1. Clin Pharmacol Ther. 1982 Jan;31(1):95-103 - PubMed
    1. Biosci Rep. 1987 Mar;7(3):167-85 - PubMed

Publication types